Solara Active Pharma Sciences Limited
NSE: SOLARA | Information Technology
Market Fundamentals
Stock Intelligence & News
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings conference call pertaining to financial results of the Company for the quarter and year ended March 31, 2026. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding the approval and adoption of Board Evaluation policy and amendment to Whistle Blower Policy. |SUBJECT: General Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |SUBJECT: Statement of deviation(s) or variation(s) under Reg. 32
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 2,200 Equity Shares pursuant to exercise of ESOP Options. |SUBJECT: ESOP/ESOS/ESPS
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding the reappointment of Internal Auditor and Cost Auditor for the FY 2026-27. |SUBJECT: General Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Conversion Of Partly Paid Up Rights Equity Shares into Fully Paid Up Equity Shares in Relation to The Rights Issue by the Company, upon receipt of the Second and Final Call Monies |SUBJECT: Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Strong Q4 26 Results and a solid finish to the fiscal Year". |SUBJECT: Press Release
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, to consider and approve the audited Standalone and Consolidated Financial Results for the year ended March 31, 2026 and unaudited Financial Results for the quarter ended March 31, 2026, along with the Auditor's report for the said period. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Why these 9 stocks will remain in focus on Wednesday: Vedanta, RVNL, BHEL, OneSource, Wanbury, Solara Active, Adroit Infotech, Enviro infra, MobiKwik
BHEL signs technology transfer pact with DRDO lab; EIE Renewables to acquire Suyog Urja; Peak XV exits MobiKwik stake
Read Full Analysis →Solara Active Pharma Sciences Limited
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026 |SUBJECT: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Read Full Analysis →Get instant alerts when SOLARA breaks news
Join investors who track Solara Active Pharma Sciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SOLARA?
SOLARA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Solara Active Pharma Sciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SOLARA to your custom watchlist.